Literature DB >> 19293953

Much ado about small differences.

Joseph P McEvoy1.   

Abstract

Year:  2009        PMID： 19293953      PMCID： PMC2645009          DOI： 10.1002/j.2051-5545.2009.tb00202.x

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  6 in total

1.  Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry.

Authors:  Roy H Perlis; Clifford S Perlis; Yelena Wu; Cindy Hwang; Megan Joseph; Andrew A Nierenberg
Journal:  Am J Psychiatry       Date:  2005-10       Impact factor: 18.112

Review 2.  Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics.

Authors:  Stephan Heres; John Davis; Katja Maino; Elisabeth Jetzinger; Werner Kissling; Stefan Leucht
Journal:  Am J Psychiatry       Date:  2006-02       Impact factor: 18.112

3.  Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study.

Authors:  Jari Tiihonen; Kristian Wahlbeck; Jouko Lönnqvist; Timo Klaukka; John P A Ioannidis; Jan Volavka; Jari Haukka
Journal:  BMJ       Date:  2006-07-06

4.  Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.

Authors:  Nina Schooler; Jonathan Rabinowitz; Michael Davidson; Robin Emsley; Philip D Harvey; Lili Kopala; Patrick D McGorry; Ilse Van Hove; Marielle Eerdekens; Wim Swyzen; Goedele De Smedt
Journal:  Am J Psychiatry       Date:  2005-05       Impact factor: 18.112

5.  All-cause treatment discontinuation in schizophrenia during treatment with olanzapine relative to other antipsychotics: an integrated analysis.

Authors:  Charles M Beasley; Virginia L Stauffer; Hong Liu-Seifert; Cindy C Taylor; Eduardo Dunayevich; John M Davis
Journal:  J Clin Psychopharmacol       Date:  2007-06       Impact factor: 3.153

6.  Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.

Authors:  Wolfgang Gaebel; Mathias Riesbeck; Wolfgang Wölwer; Ansgar Klimke; Matthias Eickhoff; Martina von Wilmsdorff; Maria C Jockers-Scherübl; Kai-Uwe Kühn; Matthias Lemke; Andreas Bechdolf; Stefan Bender; Detlef Degner; Ralf Schlösser; Lutz G Schmidt; Andrea Schmitt; Markus Jäger; Gerd Buchkremer; Peter Falkai; Stefan Klingberg; Wolfgang Köpcke; Wolfgang Maier; Heinz Häfner; Christian Ohmann; Hans J Salize; Frank Schneider; Hans-Jürgen Möller
Journal:  J Clin Psychiatry       Date:  2007-11       Impact factor: 4.384
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.